Cargando…

Metabotropic glutamate receptor subtype 3 gates acute stress-induced dysregulation of amygdalo-cortical function

Stress can precipitate or worsen symptoms of many psychiatric disorders by dysregulating glutamatergic function within the prefrontal cortex (PFC). Previous studies suggest that antagonists of group II metabotropic glutamate (mGlu) receptors (mGlu(2) and mGlu(3)) reduce stress-induced anhedonia thro...

Descripción completa

Detalles Bibliográficos
Autores principales: Joffe, Max E., Santiago, Chiaki I., Engers, Julie L., Lindsley, Craig W., Conn, P. Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013320/
https://www.ncbi.nlm.nih.gov/pubmed/29269844
http://dx.doi.org/10.1038/s41380-017-0015-z
Descripción
Sumario:Stress can precipitate or worsen symptoms of many psychiatric disorders by dysregulating glutamatergic function within the prefrontal cortex (PFC). Previous studies suggest that antagonists of group II metabotropic glutamate (mGlu) receptors (mGlu(2) and mGlu(3)) reduce stress-induced anhedonia through actions in the PFC, but the mechanisms by which these receptors act are not known. We now report that activation of mGlu(3) induces long-term depression (LTD) of excitatory transmission in the PFC at inputs from the basolateral amygdala. Our data suggest mGlu(3)-LTD is mediated by postsynaptic AMPAR internalization in PFC pyramidal cells, and we observed a profound impairment in mGlu(3)-LTD following a single, 20-min restraint stress exposure. Finally, blocking mGlu(3) activation in vivo prevented the stress-induced maladaptive changes to amygdalo-cortical physiology and motivated behavior. These data demonstrate that mGlu(3) mediates stress-induced physiological and behavioral impairments and further support the potential for mGlu(3) modulation as a treatment for stress-related psychiatric disorders.